Proskauer represented Flagship Pioneering in the transaction. Flagship Pioneering (“Flagship”), a bioplatform innovation company, raised an additional $3.6 billion of capital to fund the creation and...
You must be a Standard 1 Year member to access this content.
Goodwin advised Flagship Pioneering on the matter. Hogan Lovells acted for Omega Therapeutics, Inc. Novo Nordisk, Omega Therapeutics, Inc. (Nasdaq: OMGA) and Cellarity Inc. announced that Novo Nordisk...
You must be a Standard 1 Year member to access this content.
Goodwin advised Flagship Pioneering on the investment. Evelo Biosciences, Inc. (Nasdaq:EVLO) announced a securities purchase agreement with investors in a private placement to sell 11,025,334 shares of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Flagship Pioneering on the deal. Flagship Pioneering announced its collaboration agreement with Novo Nordisk A/S to create a portfolio of novel research programs...
You must be a Standard 1 Year member to access this content.
Proskauer advised Flagship Pioneering on the transaction. Flagship Pioneering, which conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability, completed the...
You must be a Standard 1 Year member to access this content.
